Is less regulation by the Food and Drug Administration good for the biotech industry? Do vaccine makers like Pfizer have a target on their back now? And will the “Make America Healthy Again” movement helmed by Robert F. Kennedy Jr. dampen the obesity drug market?
We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. To dig into how the election results could affect all things biopharma, we brought on three guests for this episode: Lizzy Lawrence, STAT’s FDA reporter, Baird analyst Brian Skorney, and longtime biotech executive Daphne Zohar.
For more on what Trump’s second term means for the FDA, go here; to learn about the key figures in the MAHA movement, go here; and for more on how leaders in the biopharma industry have reacted to the election, go here.
Be sure to sign up for “The Readout LOUD” on Apple Podcasts, Spotify, TuneIn, or wherever you get your podcasts.
